"Revolutionizing Vitiligo Therapy with Quantum Biology"

QUANTAIS is a quantum-enabled therapeutic platform designed to treat vitiligo through precise intracellular redox modulation. It integrates NV-diamond quantum sensors for nanoscale reactive oxygen species (ROS) detection, quantum computing-driven pulse optimization for spin chemistry control, and advanced controller modules delivering tailored RF, THz, and optical stimuli. The modular architecture consists of sensor arrays, processor units performing real-time quantum simulations and predictive control, and controller hardware for dynamic actuation. Fabrication employs high-yield PECVD diamond growth with nitrogen-15 doping and vacancy engineering to create stable near-surface NV centers optimized for live-cell environments. The system operates a closed-loop control at 10 kHz with sub-100 µs latency, ensuring rapid and precise modulation of radical-pair spin dynamics implicated in autoimmune melanocyte destruction. Performance metrics are validated via ROS suppression assays and spin relaxation benchmarks. The translational pathway includes ISO-compliant manufacturing, GLP preclinical validation, and phased clinical trials, establishing a scalable and regulatory-aligned route to clinical deployment. QUANTAIS represents a paradigm shift in quantum biology applications, delivering durable, antigen-specific immune tolerance with minimal systemic immunosuppression.